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Human leukocyte antigen- (HLA-)A,HLA-B,HLA-C,HLA-DRB1, andHLA-DQB1allele andhaplotype frequencieswere studied in
a subset of 237 volunteer bonemarrowdonors registered at the SouthAfricanBoneMarrowRegistry (SABMR).Hapl-o-Mat software
was used to compute allele andhaplotype frequencies from individuals typed at various resolutions,with some alleles inmultiple allele
code (MAC) format. Four hundred and thirty-eight HLA-A, 235HLA-B, 234HLA-DRB1, 41HLA-DQB1, and 29HLA-C alleles are
reported. The most frequent alleles were A∗ 02:02g (0.096), B∗ 07:02g (0.082), C∗ 07:02g (0.180), DQB1∗ 06:02 (0.157), and
DRB1∗ 15:01 (0.072). The most common haplotype was A∗ 03:01g~B∗ 07:02g~C∗ 07:02g~DQB1∗ 06:02~DRB1∗ 15:01
(0.067), which has also been reported in other populations. Deviations from Hardy-Weinberg equilibrium were observed in A,
B, and DRB1 loci, with C~DQB1 being the only locus pair in linkage disequilibrium. This study describes allele and haplotype
frequencies from a subset of donors registered at SABMR, the only active bone marrow donor registry in Africa. Although the
sample size was small, our results form a key resource for future population studies, disease association studies, and donor
recruitment strategies.
1. Introduction
The ~4Mb human leukocyte antigen (HLA) complex on
chromosome 6 in humans is amongst the most polymorphic
gene regions in the genome [1]. Seventeen thousand eight
hundred and seventy-four (17874) HLA alleles have been
described in the IMTG/HLA database to date [2]. HLA gene
products are key for antigen presentation to T cells and form
the basis of host defense mechanisms against pathogens [3].
HLA also plays a role in vaccine development and has a
determining role in transplantation outcome [4–11]. In
hematopoietic stem cell transplantation (HSCT), good clini-
cal outcomes are associated with high-resolution HLA
matching [12, 13], with the number of mismatches correlat-
ing with the risk of rejection and/or graft versus host disease
(GVHD) [14–16].
Bone Marrow Donors Worldwide (BMDW) is a cen-
tralized databank of HLA phenotypes and other relevant
data of unrelated stem cell donors which aims to support
HSCT programmes [17]. The South African Bone Marrow
Registry (SABMR), a nonprofit initiative based in Cape
Town, was started in 1991 with the objective of providing
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HLA-matched unrelated donors for South African patients
and the world at large. The registry, listed in the BMDW,
has more than 73,000 HLA-typed volunteer donors from
South Africa [18]. Unrelated donor registries globally,
including the SABMR, increase chances of HLA matches
for many patients in need of transplantation. Despite the
high-donor numbers globally, it is still difficult to find HLA
matches for patients of Black African origin, partly because
of (a) the great genetic diversity in these populations [19]
and (b) limited information on HLA diversity [9]. Most
transplants facilitated by the SABMR are from foreign
donors, mainly due to the limited number of donors in the
registry, particularly those of Black African and Asiatic/
Indian origin [20]. There is thus a need to improve recruit-
ment from these underrepresented populations into the
SABMR, which, since 1997, has been the only registry on
the African continent supporting an HLA-matched unre-
lated donor stem cell transplantation programme [20, 21].
Donor registries continuously try to improve their
recruitment strategies through increasing donor numbers
[22], recruiting young males [23], minority recruitment
[24–26], recruiting donors with rare HLA phenotypes [27],
or alternatively using currently available HLA allele and
haplotype frequencies [25, 28]. Although there is limited
HLA diversity data for Southern Africans (reviewed in
[29]), Africans are considered to be genetically diverse [19]
as has been determined using multiple markers [30–32],
including HLA [33]. Most HLA families that exist globally
are found in African populations [34], further confirming
genetic diversity in these populations.
In this study, we describe HLA allele and haplotype fre-
quency data from 237 donors registered with the SABMR,
which serves as the source of unrelated marrow donors in
South Africa. Frequencies of HLA-A, HLA-B, HLA-C,
HLA-DRB1, and HLA-DQB1 alleles and haplotypes were
analyzed with the aim of developing a resource for disease
association, anthropology, and evolutionary studies. Fur-
thermore, these data will support models for population-
specific vaccine development [35] and will improve donor
recruitment strategies in South African populations.
2. Methods
2.1. Study Population, Data Access, and Ethics. Two hundred
and thirty-seven (237) SABMR-registered-consenting volun-
teer bone marrow donors HLA typed at varying resolutions
were included in this study. This subset was accessed follow-
ing an extensive reconsenting procedure of donors in the
SAMBR. The self-reported ethnic grouping of the study
population was Asian, Black, Chinese, Coloured, White,
and some unknown. High-resolution typing has recently
been adopted by SABMR, with most donors having low-
resolution typing (two digit) [20, 21] which did not meet
the current study criteria. For ethical compliance, the current
study had to reconsent donors to participate in the study. As
a result, only 237 of the potential 400 participants provided
consent. Ethical clearance for this study was granted by the
University of Pretoria, Faculty of Health Sciences Research
Ethics Committee (220/2015) and the SABMR Board.
Participants’ data accessed included HLA-A, HLA-B, HLA-
C, HLA-DRB1, and HLA-DQB1 loci molecular typings and
self-reported ethnicity. Some typings in this dataset were rep-
resented by multiple allele codes (MAC, formerly NMDP
allele codes) as described in https://hml.nmdp.org/MacUI/.
2.2. HLA Allele and Haplotype Frequency Analysis. Allele and
haplotype (two, three, four, and five loci) frequencies were
estimated by resolving phase and allelic ambiguities using
the expectation-maximization (EM) algorithm [36, 37] in
Hapl-o-Mat open source software [38]. This software allows
for allele verification using the IMTG/HLA database (http://
www.ebi.ac.uk/ipd/imgt/hla/) [2, 3] and recognizes ambigui-
ties including MACs. Deviations from Hardy-Weinberg
equilibrium (HWE) were assessed at locus level using a chi-
squared test [39]. Global linkage disequilibrium (LD) and
HWE were implemented in Arlequin v3.5.2 [40]. MAC
coded alleles were dropped to two-digit level resolution for
HWE and LD analysis.
3. Results
3.1. Demographics and Allele Diversity. Self-reported ethnic-
ity was not considered for analysis in this study owing to
redundancy and simplicity of this classification as previously
discussed [41, 42]. One hundred and thirty-one (131) Black,
69 Caucasian, 19 Mixed ancestry (Coloured), 15 Asian, 2
unknown, and 1 Chinese individuals were included in this
study. Nine hundred and seventy-seven (977) different possi-
ble alleles are reported in this study (Table S1). There were
438 HLA-A, 235 HLA-B, 29 HLA-C, 234 HLA-DRB1, and
41 HLA-DQB1 alleles (Table S1), with the HLA-C locus
having the lowest allelic diversity.
3.2. Hardy-Weinberg Equilibrium and Global LD Analysis.
In this donor subset, HLA-A, HLA-B, and HLA-DRB1
genotypes deviated from the expected HWE proportions
(p < 0 05), with HLA-C and HLA-DQB1 having insignifi-
cant (p > 0 05) differences between expected and observed
heterozygosity (Table 1). No significant global LD was
detected between A~B, A~C, B~C, A~DRB1, B~DRB1,
C~DRB1, A~DQB1, B~DQB1, and DRB1~DQB1 locus
pairs (Table 2). In addition, the C~DQB1 locus pair showed
significant LD (p < 0 001), as summarized in Table 2.
3.3. HLA Allele Frequency. The full list of alleles including
those derived from MACs and their frequencies are listed
in Table S1. The top 20 most frequent alleles across the five
loci are summarized in Table 3 with the top three alleles
per locus being A∗02:01g (0.096), A∗03:01g (0.093), and
A∗01:01g (0.057); B∗07:02g (0.082), B∗08:01g (0.049), and
B∗58:02 (0.048); C∗07:02g (0.180), C∗07:01g (0.104), and
C∗04:01g (0.091); DRB1∗15:01 (0.072), DRB1∗15:03 (0.065),
and DRB1∗07:01 (0.057); and DQB1∗06:02 (0.157),
DQB1∗03:01 (0.139), and DQB1∗05:01 (0.118).
3.4. HLA Haplotype Frequency. All two, three, four, and five
(extended) haplotype frequencies are detailed in Supplementary
Table 2 (Table S2), with the 20 most frequent haplotypes
summarized in Tables 4 and 5 (extended haplotypes). The
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most common computed two, three, and four loci haplotypes
were B∗ 07:02g~C∗ 07:02g (0.145), C∗ 07:02g~DRB1∗
15:01~DQB1∗ 06:02 (0.107), and B∗ 07:02g~C∗ 07:02g~
DRB1∗ 15:01~DQB1∗ 06:02 (0.108), respectively. We
report a possible 7498 two locus, 6446 three locus, and
773 four locus haplotypes in the SABMR subset of the
donors (Table s2). A∗33:95~B∗07:231N (1.08725E-06), A∗
03:01g~C∗07:02g~DQB1∗03:02 (1.03519E-06), and A∗
11:01g~C∗01:02g~DRB1∗01:01~DQB1∗05:01 (2.8507E-06)
were less frequent two, three, and four locus haplotypes,
respectively (Table S2). The twenty most frequent extended
haplotypes (five loci) are summarized in Table 5, with A
∗03:01g~B∗07:02g~C∗07:02g~DRB1∗15:01~DQB1∗06:02
being the most frequent (0.067).
4. Discussion
Although this study had a limited sample size of 237, we pro-
vide an in-depth analysis of HLA diversity in a subset of
donors in the SABMR. Mixed resolution HLA typing data
with multiple allele codes (https://hml.nmdp.org/MacUI)
were analyzed using a robust Hapl-o-Mat [38] package to
compute allele and haplotype frequencies through the EM
algorithm. In addition, the package supports typing ambigu-
ities in NMDP codes (MAC), G group and GL string formats.
Since Hapl-o-Mat does not compute LD and HWE, we
reduced all MAC-encoded typings in our data set to two digit
resolution to estimate these parameters in Arlequin v3.5.2
[40]. Although there was the possibility of underestimation
due to the loss of some allele information, global LD and
HWE deviation is important in genetic studies.
Strong LD of C~DQB1 locus pairs (p < 0 001 in Table 2)
in our study suggests limited chances of recombination
between alleles from these loci in our population hence a
greater chance of being inherited together. LD patterns of
HLA or other genes may be used to infer evolutionary relat-
edness of populations [44]. Generally, individuals with hap-
lotypes in LD are more likely to find haplomatches and
strong LD is indicative of evolutionary relatedness of those
alleles/loci. Carvalho and colleagues [45] report HLA-A,
HLA-B, and HLA-DRB1 in HWE (p > 0 05), which contrasts
to the significant deviation (p < 0 05) observed in the current
study (Table 1). Sample size and mixed typing resolution in
the current study may have affected HWE proportions.
When there is no deviation from HWE, HLA data may be
used to infer human peopling history in anthropological
studies [46]. Furthermore, there is evidence of large
HWE deviations influencing EM algorithm-based allele
and haplotype frequency estimations [47]. It is thus
important to note the sample size and mixed typing reso-
lution limitations of the current study in interpreting
HWE and LD analysis.
Taking into account the nature of the HLA data in the
current study, we report 977 possible alleles (Table S1).
HLA-C had the lowest number (29) of alleles compared to
HLA-A (438 alleles) which had the highest. There are
generally more reported HLA-B alleles in the HLA database
[2, 3]. We note though that previously most registries
routinely typed HLA-A, HLA-B, and HLA-DRB1 for new
donors with few being typed for HLA-C and HLA-DQB1
[48]. This might explain the observed allele numbers in our
study. There is an ever increasing number of alleles in the
database (currently 17,874 in the IMTG/HLA database
release 3.31) [2, 3], with South Africa contributing some
unique alleles [49, 50].
HLA-A∗ 02:01g with a frequency of 9.6% in the current
study has been reported in North West England Caucasians
at a higher frequency of 28.9% [51]. This English study
also reported B∗ 07:02g, C∗ 07:02g, and DRB1∗ 15:01 at
frequencies of 15.3%, 15.6%, and 15.9%, respectively [51],
compared to 8.2%, 18.0%, and 7.2% in the current study.
It is important to note that the fifth most common allele
in our study, namely, A∗ 30:02g (5% frequency in
Table 3 and Table S1), is identical (exon 2 and 3 amino
acid sequence) to a novel A∗ 30:02:01:03 allele previously
reported in a SABMR donor [49]. HLA-DQB1∗ 06:02
(15.7%) has been observed at higher frequencies in
previous studies in West Africans (30.8%) and Shona
Zimbabweans (24.7%) and is lower in Kenyans (14.6%),
Colombians (15.0%), and people from Papua New Guinea
(15.0%) [26]. HLA-DRB1∗ 15:01 (7.2%) in the current
study (Table 3) has been reported previously in South
African populations at varying frequencies: 11.2% in
Caucasians and 2.4% in Black Africans [26]. Additionally,
DRB1∗ 15:01 had a 3.8% frequency in Inuit women [52],
11.65% in Chinese [53], and more than 50% in North
Africans, Asians, people from Oceania, and Europeans [54].
Table 1: Hardy-Weinberg equilibrium (HWE) parameters for the
237 donors studied.
Locus Obs Het Exp Het SD Steps done p value
HLA-A 1.00000 0.96196 0.00000 1001000 <0.001∗
HLA-B 0.99554 0.97382 0.00001 1001000 0.00074∗
HLA-C 1.00000 0.93582 0.00020 1001000 0.07316
HLA-DRB1 0.98958 0.95618 0.00000 1001000 <0.001∗
HLA-DQB1 1.00000 0.91336 0.00027 1001000 0.15049
SD: standard deviation; ∗Statistically significant (p < 0 005).







A~B 1672.062 3696 1.000
A~C 845.290 1488 1.000
B~C 1220.641 2387 1.000
A~DRB1 1288.195 2256 1.000
B~DRB1 1713.476 3619 1.000
C~DRB1 847.773 1457 1.000
A~DQB1 596.485 816 1.000
B~DQB1 777.193 1309 1.000
C~DQB1 732.281 527 <0.001∗
DRB1~DQB1 802.780 799 0.456
∗Statistically significant (p < 0 005).
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The main thrust of our study has been the ability to
estimate, with high confidence, haplotype frequencies from
mixed resolution typings including MAC (https://hml.
nmdp.org/MacUI) encoded alleles [38]. No record of the
most frequent two, three, and four loci haplotypes reported
in this study (Table 4 and Table S2) is found in the allele
frequency database [2, 3, 55]. The most frequent (6.7%)
extended haplotype A∗03:01g~B∗07:02g~C∗07:02g~DRB1
∗ 15:01~DQB1∗ 06:02 has previously been reported
amongst Chinese populations at varying frequencies (0.93–
5.20%) [53] compared to our 6.7%. There is no record of
this haplotype in African populations in the AFND allele
frequency database [56]. A lower frequency (3.31%) of this
haplotype has also been reported in a German registry as
described by Sauter and colleagues [57].
Haplotype frequencies from a specific population may be
useful for resolving typing ambiguities using statistical
approaches in typing prospective individuals from the same
population [58]. It is important though to note that sample
size affects these computations, with a tendency towards hap-
lotype overestimation in small sample-sized studies [35].
Other confounders include typing ambiguity as previously
described [59]. Additionally, multilocus haplotype frequency
estimation better informs disease association studies than
allele frequency [47]. A complete list of donor registry HLA
haplotype frequencies better informs donor-patient match-
ing tools like EasyMatch® [60], NMDP HapLogic [61, 62],
and OptiMatch [63] especially for patients of African origin
who might benefit from donors in the SABMR. These tools
use haplotype frequencies to compute the likelihood of a
donor-patient match and also anticipate the most likely mis-
matches. Haplotype frequency may be used to estimate the
probability of finding a recipient match or may give an indi-
cation of the likelihood of mismatches from initial registry
searches [35]. Additionally, haplotypes are better indicators
of HLA match estimation compared to allele frequency alone
[35]. Variations in allele frequency distribution in popu-
lations in general provide insight into peopling history
[64, 65]. HLA genetic makeup of populations provides
insight into history including selective pressures by patho-
gens [33], migration, admixture, and changes in population
size [54, 66–68].
Allele and haplotype frequencies from this study high-
light the need for continued analysis by the SABMR for a bet-
ter understanding of HLA diversity in the region. There is
limited HLA diversity data for South African populations
(reviewed in [29]), despite the evident value in transplanta-
tion, donor recruitment, disease association, and population
studies. In addition, some registries specifically aim to
improve recruitment from ethnic minorities [25] to increase
the HLA diversity and hence the probability of finding an
appropriate donor for a given patient. In this context, knowl-
edge of the distribution of alleles and haplotypes in many dif-
ferent population groups, as determined by high-resolution
typing, may allow for modification of recruitment strategies.
5. Conclusions
Although results reported here are from a small subset of
SABMR registered donors, allele and haplotype frequencies
Table 3: The twenty most frequent HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 alleles from the 237 donor subset (full list in
Table S1).
A Frequency B Frequency C Frequency DRB1 Frequency DQB1 Frequency
A∗ 02:01g 0.096 B∗ 07:02g 0.082 C∗ 07:02g 0.180 DRB1∗ 15:01 0.072 DQB1∗ 06:02 0.157
A∗ 03:01g 0.093 B∗ 08:01g 0.049 C∗ 07:01g 0.104 DRB1∗ 15:03 0.065 DQB1∗ 03:01 0.139
A∗ 01:01g 0.057 B∗ 58:02 0.048 C∗ 04:01g 0.091 DRB1∗ 07:01 0.057 DQB1∗ 05:01 0.118
A∗ 24:02g 0.051 B∗ 42:01 0.039 C∗ 06:02g 0.074 DRB1∗ 13:01 0.053 DQB1∗ 02:01 0.090
A∗ 30:02g 0.050 B∗ 44:03 0.033 C∗ 08:02g 0.057 DRB1∗ 11:01 0.053 DQB1∗ 03:02 0.083
A∗ 68:02g 0.048 B∗ 15:10 0.032 C∗ 02:02g 0.051 DRB1∗ 03:01 0.046 DQB1∗ 06:03 0.068
A∗ 11:01g 0.044 B∗ 15:01g 0.031 C∗ 15:02g 0.045 DRB1∗ 04:01 0.038 DQB1∗ 04:02 0.066
A∗ 30:01g 0.043 B∗ 15:03g 0.031 C∗ 05:01g 0.045 DRB1∗ 03:02 0.034 DQB1∗ 02:02 0.063
A∗ 29:02g 0.035 B∗ 35:01g 0.031 C∗ 03:04g 0.045 DRB1∗ 13:02 0.033 DQB1∗ 05:03 0.049
A∗ 23:01g 0.034 B∗ 14:02 0.028 C∗ 12:03g 0.040 DRB1∗ 01:02 0.029 DQB1∗ 03:03 0.045
A∗ 68:01g 0.025 B∗ 58:01g 0.028 C∗ 03:03g 0.034 DRB1∗ 01:01 0.029 DQB1∗ 06:01 0.042
A∗ 43:01 0.024 B∗ 18:01g 0.026 C∗ 01:02g 0.034 DRB1∗ 15:02 0.026 DQB1∗ 03:19 0.021
A∗ 66:01g 0.023 B∗ 51:01g 0.025 C∗ 17:01g 0.028 DRB1∗ 11:02 0.021 DQB1∗ 06:04 0.021
A∗ 33:03g 0.023 B∗ 15:16 0.021 C∗ 12:02g 0.028 DRB1∗ 13:03 0.020 DQB1∗ 06:09 0.021
A∗ 34:02 0.022 B∗ 13:02g 0.021 C∗ 16:01g 0.023 DRB1∗ 11:04 0.018 DQB1∗ 04:04 0.003
A∗ 74:01g 0.020 B∗ 58:60 0.019 C∗ 14:02g 0.023 DRB1∗ 12:01 0.016 DQB1∗ 03:30 0.003
A∗ 31:01g 0.020 B∗ 53:01g 0.018 C∗ 18:01g 0.017 DRB1∗ 12:02 0.015 DQB1∗ 06:40 0.003
A∗ 24:07 0.017 B∗ 45:01g 0.018 C∗ 08:04 0.017 DRB1∗ 08:04 0.014 DQB1∗ 06:11 0.003
A∗ 02:05g 0.016 B∗ 81:01g 0.018 C∗ 07:04g 0.017 DRB1∗ 14:04 0.013 DQB1∗ 06:218 0.000
A∗ 33:01g 0.015 B∗ 27:05g 0.017 C∗ 03:02g 0.017 DRB1∗ 03:102 0.013 DQB1∗ 06:185 0.000
g: groups are expressed and null alleles with identical amino acid sequences across class I exons 2 and 3 and class II exon 2 [43].
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generated by Hapl-o-Mat tool [38] could be a useful resource
for future anthropological and population genetics studies
in South Africans. Furthermore, these findings may better
inform donor recruitment strategies for the SABMR. The
small sample size limitation of this study also highlights
the need for larger studies in order to better understand
HLA diversity in South African populations. It would also
be interesting to analyze the whole donor registry and
compare its HLA diversity data to other registries globally.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
The authors thank the SABMR donors for their willingness
to participate in this study. This research and the publication
thereof is the result of funding provided by the South Africa
Medical Research Council (SAMRC) in terms of the MRC’s
Flagships Awards Project SAMRC-RFA-UFSP-01-2013/STEM
CELLS, the SAMRC Extramural Unit for Stem Cell Research
and Therapy, the Institute for Cellular and Molecular Medi-
cine of the University of Pretoria, and the National Research
Foundation of South Africa.
Supplementary Materials
Supplementary Table 1 (Table S1): HLA-A, HLA-B, HLA-C,
HLA-DRB1, and HLA-DQB1 allele frequencies in 237 volun-
teer bone marrow donors registered in the South African
Bone Marrow Registry. The 237 individuals described herein
are a subset of all SABMR registered donors. Supplementary
Table 2 (Table S2): Two, three, four, and five loci Haplo-o-
Mat [38] estimated haplotype frequencies in 237 volunteer
bone marrow donors registered in the South African Bone
Marrow Registry. The 237 individuals described herein are
a subset of all SABMR registered donors. (Supplementary
Materials)
References
[1] L. P. Wong, R. T. H. Ong, W. T. Poh et al., “Deep whole-
genome sequencing of 100 southeast Asian Malays,” American
Journal of Human Genetics, vol. 92, no. 1, pp. 52–66, 2013.
[2] J. Robinson, J. A. Halliwell, J. D. Hayhurst, P. Flicek,
P. Parham, and S. G. E. Marsh, “The IPD and IMGT/HLA
database: allele variant databases,” Nucleic Acids Research,
vol. 43, no. D1, pp. D423–D431, 2015.
[3] J. Robinson, M. J. Waller, S. C. Fail et al., “The IMGT/HLA
database,” Nucleic Acids Research, vol. 37, Supplement 1,
pp. D1013–D1017, 2009.
[4] P. G. Beatty, K. M. Boucher, M. Mori, and E. L. Milford, “Prob-
ability of finding HLA-mismatched related or unrelated
marrow or cord blood donors,” Human Immunology, vol. 61,
no. 8, pp. 834–840, 2000.
[5] M. Carrington and S. J. O'Brien, “The influence of HLA geno-
type on AIDS,” Annual Review of Medicine, vol. 54, no. 1,
pp. 535–551, 2003.
[6] H. Chen, Z. M. Ndhlovu, D. Liu et al., “TCR clonotypes modu-
late the protective effect of HLA class I molecules in HIV-1 infec-
tion,” Nature Immunology, vol. 13, no. 7, pp. 691–700, 2012.
Table 5: The twenty most frequent extended (five loci) haplotype frequencies from the 237 donor subset in the SABMR (full list in Table S2).
A~B~C~DQB1~DRB1 haplotype Frequency
A∗ 03:01g~B∗ 07:02g~C∗ 07:02g~DRB1∗ 15:01~DQB1∗ 06:02 0.067
A∗ 01:01g~B∗ 08:01g~C∗ 07:01g~DRB1∗ 03:01~DQB1∗ 02:01 0.050
A∗ 01:01g~B∗ 57:01g~C∗ 06:02g~DRB1∗ 07:01~DQB1∗ 03:03 0.021
A∗ 03:01g~B∗ 07:02g~C∗ 07:02g~DRB1∗ 01:01~DQB1∗ 05:01 0.017
A∗ 11:01g~B∗ 15:01g~C∗ 03:03g~DRB1∗ 13:01~DQB1∗ 06:03 0.017
A∗ 24:02g~B∗ 07:02g~C∗ 07:02g~DRB1∗ 15:01~DQB1∗ 06:02 0.017
A∗ 02:11g~B∗ 40:06~C∗ 15:02g~DRB1∗ 15:01~DQB1∗ 06:01 0.017
A∗ 33:01g~B∗ 14:02~C∗ 08:02g~DRB1∗ 13:01~DQB1∗ 06:03 0.017
A∗ 68:02g~B∗ 14:01~C∗ 08:02g~DRB1∗ 07:01~DQB1∗ 02:02 0.017
A∗ 11:01g~B∗ 51:01g~C∗ 01:02g~DRB1∗ 04:01~DQB1∗ 03:02 0.017
A∗ 31:01g~B∗ 27:05g~C∗ 02:02g~DRB1∗ 15:01~DQB1∗ 06:02 0.017
A∗ 03:01g~B∗ 07:02g~C∗ 07:02g~DRB1∗ 11:01~DQB1∗ 03:01 0.017
A∗ 68:02g~B∗ 14:02~C∗ 08:02g~DRB1∗ 13:03~DQB1∗ 03:01 0.017
A∗ 69:01~B∗ 15:17~C∗ 07:01g~DRB1∗ 11:01~DQB1∗ 03:01 0.017
A∗ 02:01g~B∗ 07:02g~C∗ 07:02g~DRB1∗ 15:01~DQB1∗ 06:02 0.017
A∗ 30:01g~B∗ 42:01~C∗ 17:01g~DRB1∗ 03:02~DQB1∗ 04:02 0.013
A∗ 24:02g~B∗ 15:32~C∗ 12:03g~DRB1∗ 12:02~DQB1∗ 03:01 0.008
A∗ 23:01g~B∗ 49:01g~C∗ 07:01g~DRB1∗ 15:02~DQB1∗ 05:03 0.008
A∗ 25:01g~B∗ 08:01g~C∗ 07:01g~DRB1∗ 03:01~DQB1∗ 02:01 0.008
A∗ 26:01g~B∗ 58:01g~C∗ 05:01g~DRB1∗ 15:03~DQB1∗ 06:02 0.008
g: groups are expressed and null alleles with identical amino acid sequences across class I exons 2 and 3 and class II exon 2 [43].
6 Journal of Immunology Research
[7] L. Garamszegi, “Global distribution of malaria-resistant
MHC-HLA alleles: the number and frequencies of alleles and
malaria risk,” Malaria Journal, vol. 13, no. 1, p. 349, 2014.
[8] T. Ndung'u, S. Gaseitsiwe, E. Sepako et al., “Major histo-
compatibility complex class II (HLA-DRB and -DQB) allele
frequencies in Botswana: association with human immuno-
deficiency virus type 1 infection,” Clinical and Diagnostic
Laboratory Immunology, vol. 12, no. 9, pp. 1020–1028, 2005.
[9] M. Ramsay, “Africa: continent of genome contrasts with impli-
cations for biomedical research and health,” FEBS Letters,
vol. 586, no. 18, pp. 2813–2819, 2012.
[10] C. Brander, N. Frahm, and B. D. Walker, “The challenges of
host and viral diversity in HIV vaccine design,” Current Opin-
ion in Immunology, vol. 18, no. 4, pp. 430–437, 2006.
[11] I. G. Ovsyannikova and G. A. Poland, “Vaccinomics: current
findings, challenges and novel approaches for vaccine develop-
ment,” The AAPS Journal, vol. 13, no. 3, pp. 438–444, 2011.
[12] H. Kunze-Schumacher, R. Blasczyk, and C. Bade-Doeding,
“Soluble HLA technology as a strategy to evaluate the impact
of HLA mismatches,” Journal of Immunology Research,
vol. 2014, Article ID 246171, 8 pages, 2014.
[13] S. J. Lee, J. Klein, M. Haagenson et al., “High-resolution donor-
recipient HLA matching contributes to the success of unre-
lated donor marrow transplantation,” Blood, vol. 110, no. 13,
pp. 4576–4583, 2007.
[14] E. W. Petersdorf, “Optimal HLA matching in hematopoietic
cell transplantation,” Current Opinion in Immunology, vol. 20,
no. 5, pp. 588–593, 2008.
[15] D. Furst, C. Muller, V. Vucinic et al., “High-resolution HLA
matching in hematopoietic stem cell transplantation: a retro-
spective collaborative analysis,” Blood, vol. 122, no. 18,
pp. 3220–3229, 2013.
[16] J. Pidala, T. Wang, M. Haagenson et al., “Amino acid substitu-
tion at peptide-binding pockets of HLA class I molecules
increases risk of severe acute GVHD and mortality,” Blood,
vol. 122, no. 22, pp. 3651–3658, 2013.
[17] “Worldwide, B.M.D,” https://www.bmdw.org/.
[18] “Worldwide, B.M.D,” https://www.bmdw.org/numberofdonors/.
[19] T. R. Disotell, “Archaic human genomics,” American Journal
of Physical Anthropology, vol. 149, no. S55, pp. 24–39, 2012.
[20] E. du Toit, T. Schlaphoff, and V. Borrill, “The South African
Bone Marrow Registry– role in providing unrelated donors
for allogeneic stem cell transplantation,” Continuing Medical
Education, vol. 30, no. 8, pp. 293-294, 2012.
[21] E. D. du Toit, V. Borrill, and T. E.-A. Schlaphoff, “The South
African Bone Marrow Registry (SABMR) in 2004,” Transfu-
sion and Apheresis Science, vol. 32, no. 1, pp. 25-26, 2005.
[22] C. Kollman, E. Abella, R. L. Baitty et al., “Assessment of opti-
mal size and composition of the U.S. National Registry of
hematopoietic stem cell donors,” Transplantation, vol. 78,
no. 1, pp. 89–95, 2004.
[23] A. H. Schmidt, L. Biesinger, D. Baier, P. Harf, and C. Rutt,
“Aging of registered stem cell donors: implications for donor
recruitment,” Bone Marrow Transplantation, vol. 41, no. 7,
pp. 605–612, 2008.
[24] J. H. Laver, T. C.Hulsey, J. P. Jones,M.Gautreaux, J. C. Barredo,
and M. R. Abboud, “Assessment of barriers to bone marrow
donation by unrelated African-American potential donors,”
Biology of Blood and Marrow Transplantation, vol. 7, no. 1,
pp. 45–48, 2001.
[25] K. A. Johansen, J. F. Schneider, M. A. McCaffree, G. L. Woods,
and the Council on Science and Public Health, American
Medical Association, “Efforts of the United States’ National
Marrow Donor Program and Registry to improve utilization
and representation of minority donors,” TransfusionMedicine,
vol. 18, no. 4, pp. 250–259, 2008.
[26] A. H. Schmidt, U. V. Solloch, D. Baier et al., “Criteria for initi-
ation and evaluation of minority donor programs and applica-
tion to the example of donors of Turkish descent in Germany,”
Bone Marrow Transplantation, vol. 44, no. 7, pp. 405–412,
2009.
[27] A. H. Schmidt, A. Stahr, D. Baier, S. Schumacher, G. Ehninger,
and C. Rutt, “Selective recruitment of stem cell donors with
rare human leukocyte antigen phenotypes,” Bone Marrow
Transplantation, vol. 40, no. 9, pp. 823–830, 2007.
[28] J. Pingel, U. V. Solloch, J. A. Hofmann, V. Lange, G. Ehninger,
and A. H. Schmidt, “High-resolution HLA haplotype fre-
quencies of stem cell donors in Germany with foreign parent-
age: how can they be used to improve unrelated donor
searches?,” Human Immunology, vol. 74, no. 3, pp. 330–340,
2013.
[29] M. Tshabalala, J. Mellet, and M. S. Pepper, “Human leukocyte
antigen diversity: a Southern African perspective,” Journal of
Immunology Research, vol. 2015, Article ID 746151, 11 pages,
2015.
[30] Y. S. Chen, A. Torroni, L. Excoffier, A. S. Santachiara-Benere-
cetti, and D. C. Wallace, “Analysis of mtDNA variation in
African populations reveals the most ancient of all human
continent-specific haplogroups,” American Journal of Human
Genetics, vol. 57, no. 1, pp. 133–149, 1995.
[31] L. B. Jorde, W. S. Watkins, M. J. Bamshad et al., “The distribu-
tion of human genetic diversity: a comparison of mitochon-
drial, autosomal, and Y-chromosome data,” American
Journal of Human Genetics, vol. 66, no. 3, pp. 979–988, 2000.
[32] E. Zigtkiewicz, V. Yotova, M. Jarnik et al., “Nuclear DNA
diversity in worldwide distributed human populations,” Gene,
vol. 205, no. 1-2, pp. 161–171, 1997.
[33] F. Prugnolle, A. Manica, M. Charpentier, J. F. Guégan,
V. Guernier, and F. Balloux, “Pathogen-driven selection and
worldwide HLA class I diversity,” Current Biology, vol. 15,
no. 11, pp. 1022–1027, 2005.
[34] K. Cao, A. M. Moormann, K. E. Lyke et al., “Differentiation
between African populations is evidenced by the diversity of
alleles and haplotypes of HLA class I loci,” Tissue Antigens,
vol. 63, no. 4, pp. 293–325, 2004.
[35] P. A. Gourraud, D. J. Pappas, A. Baouz, M. L. Balère,
F. Garnier, and E. Marry, “High-resolution HLA-A, HLA-B,
and HLA-DRB1 haplotype frequencies from the French Bone
Marrow Donor Registry,” Human Immunology, vol. 76,
no. 5, pp. 381–384, 2015.
[36] J. C. Long, R. C. Williams, and M. Urbanek, “An E-M algo-
rithm and testing strategy for multiple-locus haplotypes,”
American Journal of Human Genetics, vol. 56, no. 3, pp. 799–
810, 1995.
[37] A. P. Dempster, N. M. Laird, and D. B. Rubin, “Maximum like-
lihood from incomplete data via the EM algorithm,” Journal of
the Royal Statistical Society. Series B (Methodological), vol. 39,
no. 1, pp. 1–38, 1977.
[38] C. Schäfer, A. H. Schmidt, and J. Sauter, “Hapl-o-Mat: open-
source software for HLA haplotype frequency estimation from
ambiguous and heterogeneous data,” BMC Bioinformatics,
vol. 18, no. 1, p. 284, 2017.
7Journal of Immunology Research
[39] S. W. Guo and E. A. Thompson, “Performing the exact test of
Hardy-Weinberg proportion for multiple alleles,” Biometrics,
vol. 48, no. 2, pp. 361–372, 1992.
[40] L. Excoffier and H. E. L. Lischer, “Arlequin suite ver 3.5: a new
series of programs to perform population genetics analyses
under Linux and Windows,” Molecular Ecology Resources,
vol. 10, no. 3, pp. 564–567, 2010.
[41] G. Barbujani, S. Ghirotto, and F. Tassi, “Nine things to remem-
ber about human genome diversity,” Tissue Antigens, vol. 82,
no. 3, pp. 155–164, 2013.
[42] T. B. Mersha and T. Abebe, “Self-reported race/ethnicity in the
age of genomic research: its potential impact on understanding
health disparities,” Human Genomics, vol. 9, no. 1, p. 1, 2015.
[43] A. H. Schmidt, D. Baier, U. V. Solloch et al., “Estimation of
high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype
frequencies based on 8862 German stem cell donors and
implications for strategic donor registry planning,” Human
Immunology, vol. 70, no. 11, pp. 895–902, 2009.
[44] J. Martinez-Laso, M. Sartakova, L. Allende et al., “HLA molec-
ular markers in Tuvinians: a population with both Oriental
and Caucasoid characteristics,” Annals of Human Genetics,
vol. 65, no. 3, pp. 245–261, 2001.
[45] M. G. Carvalho, L. T. Tsuneto, J. M. Moita Neto et al., “HLA-
A, HLA-B and HLA-DRB1 haplotype frequencies in Piauí’s
volunteer bone marrow donors enrolled at the Brazilian regis-
try,” Human Immunology, vol. 74, no. 12, pp. 1598–1602,
2013.
[46] I. Romòn, C. Montes, D. Ligeiro et al., “Mapping the HLA
diversity of the Iberian peninsula,” Human Immunology,
vol. 77, no. 10, pp. 832–840, 2016.
[47] R. M. Single, D. Meyer, J. A. Hollenbach et al., “Haplotype fre-
quency estimation in patient populations: the effect of depar-
tures from Hardy-Weinberg proportions and collapsing over
a locus in the HLA region,” Genetic Epidemiology, vol. 22,
no. 2, pp. 186–195, 2002.
[48] C. K. Hurley, M. Maiers, S. G. E. Marsh, and M. Oudshoorn,
“Overview of registries, HLA typing and diversity, and search
algorithms,” Tissue Antigens, vol. 69, pp. 3–5, 2007.
[49] J. D. Hayhurst, E. D. du Toit, V. Borrill, T. E. A. Schlaphoff,
N. Brosnan, and S. G. E. Marsh, “Two novel HLA alleles,
HLA-A∗30:02:01:03 and HLA-C∗08:113, identified in a South
African bone marrow donor,” Tissue Antigens, vol. 85, no. 4,
pp. 291–293, 2015.
[50] M. Paximadis, T. Y. Mathebula, N. L. Gentle et al., “Human
leukocyte antigen class I (A, B, C) and II (DRB1) diversity in
the black and Caucasian South African population,” Human
Immunology, vol. 73, no. 1, pp. 80–92, 2012.
[51] A. Alfirevic, F. Gonzalez-Galarza, C. Bell et al., “In silico anal-
ysis of HLA associations with drug-induced liver injury: use of
a HLA-genotyped DNA archive from healthy volunteers,”
Genome Medicine, vol. 4, no. 6, p. 51, 2012.
[52] S. Metcalfe, M. Roger, M. C. Faucher, F. Coutlée, E. L. Franco,
and P. Brassard, “The frequency of HLA alleles in a population
of Inuit women of northern Quebec,” International Journal of
Circumpolar Health, vol. 72, no. 1, 2013.
[53] X.-Y. Zhou, F. M. Zhu, J. P. Li et al., “High-resolution analyses
of human leukocyte antigens allele and haplotype frequencies
based on 169,995 volunteers from the China Bone Marrow
Donor Registry Program,” PLoS One, vol. 10, no. 9, article
e0139485, 2015.
[54] A. Sanchez-Mazas, M. Fernandez-Viña, D. Middleton et al.,
“Immunogenetics as a tool in anthropological studies,” Immu-
nology, vol. 133, no. 2, pp. 143–164, 2011.
[55] http://www.who.int/hiv/pub/arv/summary-recommendations.
pdf?ua=1.
[56] F. F. González-Galarza, L. Y. C. Takeshita, E. J. M. Santos et al.,
“Allele frequency net 2015 update: new features for HLA
epitopes, KIR and disease and HLA adverse drug reaction
associations,” Nucleic Acids Research, vol. 43, no. D1,
pp. D784–D788, 2015.
[57] J. Sauter, U. V. Solloch, A. S. Giani, J. A. Hofmann, and A. H.
Schmidt, “Simulation shows that HLA-matched stem cell
donors can remain unidentified in donor searches,” Scientific
Reports, vol. 6, no. 1, p. 21149, 2016.
[58] P. A. Gourraud, P. Lamiraux, N. el-Kadhi, C. Raffoux, and
A. Cambon-Thomsen, “Inferred HLA haplotype information
for donors from hematopoietic stem cells donor registries,”
Human Immunology, vol. 66, no. 5, pp. 563–570, 2005.
[59] E. C. Castelli, C. T. Mendes-Junior, L. C. Veiga-Castelli, N. F.
Pereira, M. L. Petzl-Erler, and E. A. Donadi, “Evaluation of
computational methods for the reconstruction of HLA haplo-
types,” Tissue Antigens, vol. 76, no. 6, pp. 459–466, 2010.
[60] V. Dubois, M. Detrait, M. Sobh et al., “Using EasyMatch® to
anticipate the identification of an HLA identical unrelated
donor: a validated efficient time and cost saving method,”
Human Immunology, vol. 77, no. 11, pp. 1008–1015, 2016.
[61] J. Dehn, M. Setterholm, K. Buck et al., “HapLogic: a predictive
human leukocyte antigen-matching algorithm to enhance
rapid identification of the optimal unrelated hematopoietic
stem cell sources for transplantation,” Biology of Blood and
Marrow Transplantation, vol. 22, no. 11, pp. 2038–2046, 2016.
[62] L. Gragert, M. Eapen, E. Williams et al., “HLA match likeli-
hoods for hematopoietic stem-cell grafts in the U.S. Registry,”
New England Journal of Medicine, vol. 371, no. 4, pp. 339–348,
2014.
[63] W. Bochtler, M. Beth, H. P. Eberhard, and C. R. Mueller,
“OptiMatch®-a universally configurable HLA matching
framework,” in 22nd European Immunogenetics and Histo-
compatibility Conference, pp. 265–398, Berne, Switzerland,
2008.
[64] A. Arnaiz-Villena, R. Reguera, C. Parga-Lozano et al., “HLA
genes in Afro-American Colombians (San Basilio de Palen-
que): the first free Africans in America,” The Open Immunol-
ogy Journal, vol. 2, no. 1, pp. 59–66, 2009.
[65] A. Arnaiz-Villena, J. Palacio-Grüber, E. Muñiz et al., “Genetic
HLA study of Kurds in Iraq, Iran and Tbilisi (Caucasus, Geor-
gia): relatedness and medical implications,” PLoS One, vol. 12,
no. 1, article e0169929, 2017.
[66] S. Buhler and A. Sanchez-Mazas, “HLA DNA sequence varia-
tion among human populations: molecular signatures of
demographic and selective events,” PLoS One, vol. 6, no. 2,
article e14643, 2011.
[67] P. Parham and T. Ohta, “Population biology of antigen presen-
tation by MHC class I molecules,” Science, vol. 272, no. 5258,
pp. 67–74, 1996.
[68] G. H. Kijak, A. M. Walsh, R. N. Koehler et al., “HLA class I
allele and haplotype diversity in Ugandans supports the pres-
ence of a major east African genetic cluster,” Tissue Antigens,
vol. 73, no. 3, pp. 262–269, 2009.
















































































Submit your manuscripts at
www.hindawi.com
